Supreme Court rules for the FDA in flavored vapes dispute

Supreme Court rules for the FDA in flavored vapes dispute


A person uses a vape pen near Bryant Park on December 02, 2024 in New York City. 

Michael M. Santiago | Getty Images

The Supreme Court on Wednesday handed a win to the Food and Drug Administration over its refusal to approve flavored e-cigarettes.

The court threw out an appeals court ruling that found the agency unlawfully changed the rules in the middle of proceedings when it was deciding whether to approve various products.

With e-cigarettes, or vapes, more popular than ever, the case put the FDA’s role in the approval process under scrutiny. Despite the agency’s refusal to approve many products, flavored vapes have remained widely available.

Writing for a unanimous court, conservative Justice Samuel Alito stopped short of ruling definitively that the FDA had acted unlawfully on one particular aspect of the case: whether the agency should have considered the companies’ marketing plans as part of the approval process.

That issue will now be decided by the lower court.

But Alito said that the FDA’s decisions were otherwise sound, noting that the companies’ own applications are “strong evidence that regulated entities had adequate notice of the sort of comparative analysis the FDA anticipated.”

The FDA, then under the Biden administration, appealed to the Supreme Court after the New Orleans-based 5th U.S. Circuit Court of Appeals ruled that it had incorrectly handled the approval requests made by manufacturers, thereby violating the federal Administrative Procedure Act.

The agency has won similar cases in other courts.

Triton Distribution, which makes e-liquids for vape pens with flavors like Signature Series Mom’s Pistachio and Suicide Bunny Mother’s Milk and Cookies, is one of the companies involved. The other is Vapestasia, which has sought approval for Iced Pineapple Express, Killer Kustard Blueberry and other flavors.

The FDA has said flavored vapes pose a health risk because they could encourage young people to use tobacco.

The companies could face potential civil and criminal penalties for marketing products without approval. They argued the FDA got it wrong in denying the approvals, saying that flavored vapes can be used to help people stop smoking.

Their lawyers said the FDA changed its standard for considering flavored vapes in the middle of the process without giving applicants adequate warning.

The agency responded in court that it evaluates each application on its merits and that the companies had failed to provide sufficient evidence for their claims.

The FDA began regulating vape products in 2016 after they were already on the market. At the time, the agency said it would not take enforcement actions while companies sought approval.

It subsequently concluded that the potential benefits of helping adult smokers quit do not outweigh the potential health risks to young people, who are most attracted to nontobacco-flavored vapes.

The FDA has given its approval to menthol-flavored e-cigarettes, as well as some that are tobacco-flavored.



Source

Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale
Health

Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale

Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill market. Eli Lilly stock slipped about half a percent this morning, while Novo Nordisk shares surged more than 8% after becoming the first to secure FDA approval for a GLP-1 weight-loss pill. “[Novo] got approval ahead of […]

Read More
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
Health

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, Nov. 24, 2025. Tom Little | Reuters The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts […]

Read More
UnitedHealth Group commits to improvements after independent audit, patient backlash
Health

UnitedHealth Group commits to improvements after independent audit, patient backlash

UnitedHealthcare sign is displayed at its office building in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans | Reuters UnitedHealth Group on Friday released the first results from a sprawling independent audit of its business practices and committed to a wide range of steps to track and implement improvements in three specific areas. The health-care […]

Read More